Manzanilla SM

Language: Spanish
References: 7
Page: 38-39
PDF size: 27.35 Kb.

Text Extraction

No abstract

REFERENCES

1. Stupack DG, Cheresh DA. Integrins and Angiogenesis. Curr Top Dev Biol 2004; 84: 207-238.

2. Nakayama Y, Sako T, Shibao K, Okazaki K, Rempo N, Onitsuka K, Minagawa N, Akahane K, Nagashima N, Nagata N, Itoh H. Prognostic value of plasma vascular endothelial growth factor in patients with colorectal cancer. Anticancer Res 2002; 22(4): 2437-42.

3. Werther K, Christensen IJ, Brunner N, Nielsen HJ. Soluble vascular endothelial growth factor levels in patients with primary colorectal carcinoma. The Danish RANX05 Colorectal Cancer Study Group. Eur J Surg Oncol 2000; 26(7): 657-62.

4. Prognostic impact of matched preoperative plasma and serum VEGF in patients with primary colorectal carcinoma. Br J Cancer 2002; 86(3): 417-23.

5. Werther K, Christensen IJ, Nielsen HJ. Danish RANX05 Colorectal Cancer Study Group: The association between preoperative concentration of soluble vascular endothelial growth factor, perioperative blood transfusion, and survival in patients with primary colorectal cancer. Eur J Surg 2001; 167(4): 287-92.

6. Landriscina M, Cassano A, Ratto C, Longo R, Ippoliti M, Palazzotti B, Crucitti F, Barone C. Quantitative analysis of basic fibroblast growth factor and vascular endothelial growth factor in human colorectal cancer. Br J Cancer 1998; 78(6): 765-70.

7. Davies MM, Jonas SK, Kaur S, Allen-Mersh TG. Plasma vascular endothelial but not fibroblast growth factor levels correlate with colorectal liver metastasis vascularity and volume. Br J Cancer 2000; 82(5): 1004-8.